Skip to main content

US ClosedU.S. Closed

XTLB: XTL Biopharmaceuticals Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions.

52W Range

6thpctl

Volume

0.10×avg

Market Cap

2.34MUSD

P/E Ratio

-0.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

XTL Biopharmaceuticals Ltd.

XTLBNASDAQ Capital Market·USD·Closed

XTL Biopharmaceuticals Ltd.

XTLBNASDAQ·USD·Closed

$2.47

−4.26%

$2.47

−$0.11 (4.26%)

52W Range

6thpctl

Volume

0.10×avg

Mkt Cap

2.34MUSD

P/E

-0.8TTM

Div Yield

–ann